Trust Layer for Existing Models
RI for Pharmaceutical Development
A refinement layer that improves accuracy, reliability, and auditability of AI across the full product lifecycle.
Pharmaceutical teams already use AI in discovery models, trial analytics, process control, forecasting, and safety monitoring. Those systems are powerful, yet they can still produce systematic error patterns that degrade accuracy, reduce reliability under real constraints, and leave limited process records for inspection or defense.
RI is a modular refinement platform that sits with your existing models. It evaluates outputs for accuracy and performance issues, applies corrective processing, supports multi-dimensional calibration, monitors robustness, and generates detailed, human-readable process records for every refinement action. It works without requiring full model replacement or change governance layers, and can be applied from early research through commercial supply and post-market surveillance.
Example use cases across core domains. RI applies consistently wherever AI-assisted decisions affect quality, speed, or compliance. It is not limited to a single stage.
Research & Development (R&D) and Drug Discovery
Improves model accuracy on target identification, hit selection, and early property prediction by flagging error patterns and enforcing domain constraints. Process records travel with hypotheses for later documentation.
Clinical Development
Supports more reliable protocol design, stratification, and interim analysis by calibrating model outputs against biological and regulatory constraints and logging corrective steps for trial files.
Regulatory Affairs & Compliance
Generates auditable process records for AI-influenced language, risk assessments, and consistency checks across submissions. Helps surface accuracy issues before they reach health-authority packages.
Manufacturing & Operations
Monitors process models for performance drift relative to critical quality attributes. Robustness monitoring on threshold breach and keeps batch-related records inspection-ready.
Supply Chain, Logistics & Serialization
Improves forecasting and risk scoring accuracy by resolving multi-source conflicts and documenting the reasoning path. Supports rapid stabilization when disruption signals appear.
Commercialization, Sales & Marketing
Raises reliability of forecasting, segmentation, and content models. Process records assist medical-legal review of AI-assisted materials.
Market Access & Health Economics
Strengthens value and comparative models by calibrating claims to underlying evidence and logging multi-source synthesis for payer or HTA defense.
Pharmacovigilance (PV) & Drug Safety
Enhances signal detection and evaluation by identifying error patterns in literature or case models, applying safety-specific constraints, and maintaining continuous process records for case processing and aggregate reporting.
Technical integration notes
01
Modular layer that wraps or observes existing inference pipelines (text, imaging, multimodal, or hybrid).
02
Post-training: Receives outputs and metadata from any base model through a standard interface, applies evaluation and corrective steps, and returns refined results plus process records. Latency and compute can be tuned; lighter modules are available for high-volume paths. No modification of underlying model weights or architecture.
03
Training-time: Injects accuracy-focused signals into the optimization loop during fine-tuning so improved representations are internalized in the weights.
04
Core refinement can be extended with domain-specific modules for chemistry, clinical constraints, regulatory language, manufacturing ranges, or safety logic. Modules can run full, partial, or distilled.
05
Deployment: Hosted API, private cloud, or on-premises/air-gapped options. Architecture supports disconnected manufacturing and certain clinical settings. Flexibility: attach for a time-boxed evaluation or leave in place for ongoing use as models and processes mature.
06
Connectors: Standard interfaces to model-serving endpoints, data platforms, document systems, and quality workflows.
Organizations can pilot on a single workflow and expand the same refinement layer across additional stages without re-architecting core systems.
Built for Regulated, High-Stakes Operations
In pharmaceutical work the cost of undetected accuracy issues appears in delayed decisions, manufacturing deviations, missed signals, and inspection findings. RI treats those issues as an engineering problem: continuous evaluation, corrective processing, multi-path resolution, robustness monitoring, and complete process records.
The same layer travels with the program—from early discovery through clinical evidence, regulatory defense, manufacturing control, supply resilience, commercial execution, and ongoing safety surveillance—raising the reliability and defensibility of AI-assisted work at every step.